[Malignant lymphoma in the horse: an atypical clinical manifestation].

The case study focuses on an unexpected manifestation of malignant lymphoma in a horse, characterized by redness in the mucous membrane (hyperaemic mucosae) and skin lesions. The study suggests that these symptoms were mainly caused by a form of leukemia.

Case Report Description

• This case report involves the study of a unique instance of malignant lymphoma in a horse, that shows unusual clinical symptoms. The standard representations of malignant lymphoma in animals are not the focus here.
• The sign that stood out the most is hyperaemic mucosae, a medical condition wherein the mucous membrane becomes abnormally filled with blood, along with skin lesions. Normally, lymphoma in horses is identified through weight loss, loss of appetite, or abdominal discomfort. In this case, the lymphoma manifested differently.

Etiology of the Clinical Symptoms

• Researchers found that the skin and mucosal lesions were primarily caused by a leukemic form of malignant lymphoma. Leukemic lymphoma spreads in the bloodstream, affecting various parts of the body, which explains the skin and mucosal involvement in this particular case.
• The leukemic form of lymphoma seen was characterized by an abundance of different populations of T-lymphocytes. T-lymphocytes are a type of white blood cell that matures in the thymus gland and is responsible for the body’s immune response.

Identification and Characterization of the Lymphoma

• Using histopathological and immunohistochemical analysis, the researchers were able to properly identify the type of lymphoma.
• Upon inspection, the lymphoma was identified as a T-cell rich B-cell lymphoma. This type of lymphoma is a rare variant where there are more T cells than B cells in the tumor. Although B cells are still the malignant ones, the presence of excessive T cells dominates the phenotype of the lymphoma.
• This identification helps in planning treatment, as different types of lymphomas may respond differently to various treatments and have varied prognosis.